<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Physiologic changes of pregnancy can predispose women to <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> is rare in pregnancy and usually occurs in women with underlying <z:hpo ids='HP_0001627'>cardiac anomalies</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>CASE: A young woman at 22 weeks of gestation presented with new-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> with rapid ventricular response </plain></SENT>
<SENT sid="3" pm="."><plain>Thorough evaluation revealed <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> with no underlying cause and ultimately required treatment with electrical cardioversion </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: Lone <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> in pregnancy requires exclusion of <z:hpo ids='HP_0000001'>all</z:hpo> possible etiologies before diagnosis </plain></SENT>
<SENT sid="5" pm="."><plain>Cardioversion is the treatment of choice </plain></SENT>
<SENT sid="6" pm="."><plain>Women with persistent <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> require anticoagulation and rate control, as well as fetal growth surveillance and antenatal testing </plain></SENT>
</text></document>